IT202200010199A1 - Glicerofosfoinositolo nella prevenzione e nel trattamento di infezioni da covid-19 e metodo per il suo ottenimento - Google Patents

Glicerofosfoinositolo nella prevenzione e nel trattamento di infezioni da covid-19 e metodo per il suo ottenimento Download PDF

Info

Publication number
IT202200010199A1
IT202200010199A1 IT102022000010199A IT202200010199A IT202200010199A1 IT 202200010199 A1 IT202200010199 A1 IT 202200010199A1 IT 102022000010199 A IT102022000010199 A IT 102022000010199A IT 202200010199 A IT202200010199 A IT 202200010199A IT 202200010199 A1 IT202200010199 A1 IT 202200010199A1
Authority
IT
Italy
Prior art keywords
glycerophosphoinositol
covid
obtainment
infections
prevention
Prior art date
Application number
IT102022000010199A
Other languages
English (en)
Inventor
Elena Sgaravatti
Original Assignee
Plantarei Biotech S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plantarei Biotech S R L filed Critical Plantarei Biotech S R L
Priority to IT102022000010199A priority Critical patent/IT202200010199A1/it
Priority to PCT/IB2023/055005 priority patent/WO2023223189A1/en
Publication of IT202200010199A1 publication Critical patent/IT202200010199A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT102022000010199A 2022-05-17 2022-05-17 Glicerofosfoinositolo nella prevenzione e nel trattamento di infezioni da covid-19 e metodo per il suo ottenimento IT202200010199A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102022000010199A IT202200010199A1 (it) 2022-05-17 2022-05-17 Glicerofosfoinositolo nella prevenzione e nel trattamento di infezioni da covid-19 e metodo per il suo ottenimento
PCT/IB2023/055005 WO2023223189A1 (en) 2022-05-17 2023-05-16 Glycerophosphoinositol in preventing and treating covid-19 infections and method for obtaining it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000010199A IT202200010199A1 (it) 2022-05-17 2022-05-17 Glicerofosfoinositolo nella prevenzione e nel trattamento di infezioni da covid-19 e metodo per il suo ottenimento

Publications (1)

Publication Number Publication Date
IT202200010199A1 true IT202200010199A1 (it) 2023-11-17

Family

ID=83081229

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000010199A IT202200010199A1 (it) 2022-05-17 2022-05-17 Glicerofosfoinositolo nella prevenzione e nel trattamento di infezioni da covid-19 e metodo per il suo ottenimento

Country Status (2)

Country Link
IT (1) IT202200010199A1 (it)
WO (1) WO2023223189A1 (it)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306840A (en) 1990-02-09 1994-04-26 Euticals S.P.A. Process for preparing pure L-α-glycerylphosphoryl-D-myoinositol and its salts
WO2002038575A1 (en) * 2000-11-07 2002-05-16 I.R.B. Istituto Di Ricerche Biotecnologiche S.R.L. Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
US6924130B1 (en) 1999-06-15 2005-08-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Enzymatic transesterification or hydrolysis of phospholipids in aqueous media
EP1918371A1 (en) * 2005-07-19 2008-05-07 Asahi Kasei Pharma Corporation Novel phospholipid processing agent
WO2014053642A1 (en) * 2012-10-04 2014-04-10 Consiglio Nazionale Delle Ricerche Use of glycerophosphoinositols for the treatment of septic shock
CN106459107A (zh) 2014-06-10 2017-02-22 凯米股份公司 用于纯化L‑α‑甘油磷酰胆碱的工艺

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306840A (en) 1990-02-09 1994-04-26 Euticals S.P.A. Process for preparing pure L-α-glycerylphosphoryl-D-myoinositol and its salts
US6924130B1 (en) 1999-06-15 2005-08-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Enzymatic transesterification or hydrolysis of phospholipids in aqueous media
WO2002038575A1 (en) * 2000-11-07 2002-05-16 I.R.B. Istituto Di Ricerche Biotecnologiche S.R.L. Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
EP1918371A1 (en) * 2005-07-19 2008-05-07 Asahi Kasei Pharma Corporation Novel phospholipid processing agent
WO2014053642A1 (en) * 2012-10-04 2014-04-10 Consiglio Nazionale Delle Ricerche Use of glycerophosphoinositols for the treatment of septic shock
CN106459107A (zh) 2014-06-10 2017-02-22 凯米股份公司 用于纯化L‑α‑甘油磷酰胆碱的工艺

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"pharmaceutical Sciences Handbook", 1985, MACK PUB. CO.
LLEN, LOYD V., JR: "the Science and practice of Pharmacy"

Also Published As

Publication number Publication date
WO2023223189A1 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
ZA201801266B (en) Composition and method for treatment and prophylaxis of intestinal infection and inflammation
EP3672591A4 (en) SYNERGIC ANTI-TUMOR EFFECT OF A BCL-2 INHIBITOR COMBINED WITH RITUXIMAB AND / OR BENDAMUSTINE OR A BCL-2 INHIBITOR COMBINED WITH CHOP
EP4186519A4 (en) INTERFERON-BASED CANCER TREATING METHOD AND PHARMACEUTICAL COMPOSITION
IL265292A (en) Medicinal compound and method for treating non-alcoholic fatty liver disease
IT202200010199A1 (it) Glicerofosfoinositolo nella prevenzione e nel trattamento di infezioni da covid-19 e metodo per il suo ottenimento
EP4029504A4 (en) USE OF BCL-2 INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING AGE-RELATED SKIN DISEASE
EP4132539A4 (en) COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS
TWI801004B (zh) 紅肉蘋果和櫻桃李組合物及其在降血脂方面的應用
IL300152A (en) Treatment methods using furosemide
IL286994A (en) A method for the treatment and prevention of bone and joint infections
EP4003381A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND OTHER DISEASES
EP4106874A4 (en) COMPOSITIONS AND THEIR METHODS OF USE FOR THE TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE
EP4138862A4 (en) COMPOSITIONS AND METHODS FOR TREATING UPPER AIRWAY INFECTIONS
MX2022016179A (es) Compuestos y metodos para tratar infecciones fungicas.
GB202008094D0 (en) Treatment of infections
EP4114423A4 (en) COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR BACTERIAL INFECTIONS
EP4130993A4 (en) METHOD AND APPARATUS FOR PROCESSING SPECIAL EFFECTS
EP4103192A4 (en) COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS
EP3990472A4 (en) COMPOSITIONS AND METHODS FOR TREATING FUNGAL INFECTIONS
GB202018015D0 (en) Composition and methods for the treatment of intestinal cancer
EP3606516A4 (en) METHODS OF TREATMENT AND PREVENTION OF INFECTION
IT202200007247A1 (it) Nanoparticelle di fenretinide utili nel trattamento di patologie epatiche
AU2022900343A0 (en) Compositions and methods for treating infections
CY2023002I1 (el) Συνθεσεις και χρησεις για αντιμετωπιση πολλαπλης σκληρυνσης
EP3876909A4 (en) NANODISCS FOR THE PREVENTION AND TREATMENT OF PATHOGENIC INFECTIONS AND METHODS OF USE THEREOF